Cell Manufacturing– tag –
-
Lonza Accelerates DNA-to-IND Programs with New GS Ori‑Go™ Vector Technology: Delivers Tox Material in 2 Months, IND-Ready in as Fast as 6 Months
Lonza Press Release Switzerland Overview Lonza announced the enhancement of its preclinical development services, featuring the new GS Ori‑Go™ vector technology, to significantly accelerate DNA-to-IND (Investigational New Drug) programs.... -
CDMO World Releases Validation Guide for Machine Learning in Bioreactor Optimization, Emphasizing Real-Time Control and Data Governance
CDMO World USA Overview CDMO World has published a validation guide analyzing the operational benefits and data integrity risks of applying machine learning (ML) to bioreactor optimization in commercial fermentation processes. The guide ... -
Lonza Boosts Biologics Manufacturing with Dual Expansion: Swiss ADC Capacity and Enhanced US Biopharma Partnership with N-1 Perfusion Technology
Industry Week USA Overview Lonza has significantly strengthened its biopharmaceutical manufacturing capabilities through a massive expansion of its Antibody-Drug Conjugate (ADC) production capacity in Switzerland and an extended long-ter... -
Hyperspectral Enhances Bioprocess Visibility with Real-time PAT: Raman Spectroscopy and Chemometrics Enable Non-Invasive Mammalian Cell Culture Monitoring
Hyperspectral (via analytica 2026 presentation) Unknown Overview Hyperspectral has introduced an innovative solution for real-time, non-invasive monitoring of mammalian cell culture processes by combining Raman spectroscopy with chemomet... -
FUJIFILM Biotechnologies Drives $7 Billion Expansion in US and Europe, Quadrupling iPSC Production Capacity and Automating with AI
Drug Discovery and Development USA Overview FUJIFILM Biotechnologies is leading a $7 billion expansion across the US and Europe, with FUJIFILM Cellular Dynamics opening a new iPSC manufacturing headquarters to quadruple cell production c... -
Lonza’s OptiALTO™ Platform Achieves High Cell Density Culture, Significantly Reducing Biologics Manufacturing Costs
Lonza Switzerland Overview Lonza's OptiALTO™ platform enhances biologics manufacturing by enabling higher cell densities, which significantly reduces cost of goods by increasing productivity and efficient asset utilization. The platform ... -
Biologics Outsourcing Redefined: Modality Expertise & End-to-End Integration Key for Partnerships
Bioprocess Online USA Overview Biologics manufacturing outsourcing is evolving into strategic partnerships focused on modality expertise, regulatory excellence, and end-to-end integration, moving beyond mere cost savings. To support incr... -
Novo Nordisk Partners with India’s Shantha Biologics for Global Cartridge Fill-Finish Services
The SouthFirst India Overview Novo Nordisk has signed an outsourcing agreement with Hyderabad-based Shantha Biologics for cartridge fill-finish manufacturing services for its global supply chain. This strategic collaboration signifies Sh... -
In-Line Sensors Play Crucial Role in Single-Use Biomanufacturing, Driving PAT Adoption and Enhancing Process Control
Technology Networks Global Overview In-line sensors are proving indispensable in single-use biomanufacturing for improving process efficiency and reliability. Directly integrated into single-use bioreactor bags, these sensors enable cont... -
Samsung Biologics Revolutionizes Bioprocess Manufacturing Intelligence by Integrating Digital Twin and AI for Proactive Decision-Making
Samsung Biologics South Korea Overview Samsung Biologics is revolutionizing manufacturing intelligence by advancing a digital bioprocess framework integrating multivariate data analysis (MVDA), predictive modeling, and explainable AI. Th...
